Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 SC abatacept in adults with active primary Sjogren's syndrome
jRCT2080223466Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2017
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in Sjögren's syndrome (SS) comparing Abatacept arm with Placebo arm (2 arms). Started Feb 2017; status: completed.
02
Drugs
abatacept
03
Conditions
Sjögren's syndrome (SS)
Beyond the preview
Go deeper on jRCT2080223466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223466.